C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
BuyCIN Rating 67/100How is this calculated?

Canada: LPs Reprice While Tilray's guidance and DEA timeline Loom

Canadian equities trade with dispersion: SNDL, VFF and HMMJ show modest moves while distressed Revive and biotech names spike; Tilray's fiscal-2027 EBITDA guide and DEA schedule are the near-term anchors.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.